Local Anesthesia by de Abreu Camargo, Caio Lamunier
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 1
Local Anesthesia
Caio Lamunier de Abreu Camargo
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.72930
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited. 
Caio Lamunier de Abreu Camargo
Additional information is available at the end of the chapter
Abstract
Local anesthesia is a routine procedure in dermatological practice. This chapter deals 
with the basic principles of pharmacology and pharmacodynamics related to the most 
commonly used anesthetics in dermatology as well as its side effects, the most common 
anesthetic solutions, anesthesia techniques, and topical anesthesia.
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1. Introduction
Anesthesia is a common procedure in all fields of dermatology. Knowing its pharmaco-
logical and clinical elements is essential to a good dermatological practice. Efficiency, 
safety, and comfort are the main concern. There are several anesthetics, and the choice 
of the correct one as the best application technique provides more safety, comfort, and 
efficiency.
It is not known exactly when the anesthesia began. Nitrous oxide is believed to have been 
used since 1772 by Joseph Priestley. The use of ether became famous after a public dem-
onstration by William Thomas Green Morton in 1846, but its use is older and several other 
scientists have claimed the discovery of the ether as an anesthetic. The use of local anesthetics 
gained ground in medical science in 1884, and cocaine was widely used as a local anesthetic, 
although there is evidence of its use in ancient civilizations.
We can classify dermatological anesthesia in two different groups: general anesthesia and 
local anesthesia. General anesthesia is associated with increased risks of morbidity and mor-
tality than local anesthesia. For this reason, local anesthesia is widely used in dermatological 
practice. Moreover, local anesthesia is cheaper, with less surgical time and faster recovery. 
Nevertheless, there are some limitations depending on the procedure’s extension and patient 
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discomfort and collaboration. Local anesthesia can be achieved by topical products, by infil-
trative nerve blocks, and by infiltrative tumescent anesthesia [1].
2. Local anesthesia
Nerve impulse transmission occurs when voltage-gated sodium channels on the neuronal 
membrane open, allowing massive influx of sodium into peripheral nerve cells. In resting 
state, the intracellular electric potential is negative relative to the extracellular space thanks to 
the cellular membrane and by Na+/K+ ATPase. The influx of sodium causes membrane depo-
larization and propagation of the impulse. Local anesthetics prevent nerve impulse trans-
mission by blocking sodium channels without causing central nervous system depression or 
altered mental status [2, 3].
The block generally occurs in a stepwise sequence with autonomic impulses blocked first, 
then sensory impulses, and finally motor impulses. Unmyelinated and smaller myelinated 
nerve fibers are easier to block than larger myelinated fibers. Therefore, C-type fibers are 
the first to be blocked in a local anesthesia. Pain is first controlled followed by heat and cold 
sensation. Then, B-type fibers are blocked, which are the preganglionic sympathetic fibers. 
Finally, A-type fibers are block. Proprioception, touch and pressure, and motor fibers are the 
last to suffer anesthetics effects [4].
The most used anesthetic agents have three structural components: an aromatic portion, an 
intermediate connecting chain, and an amine portion. The aromatic portion provides hydro-
phobic and lipophilic properties and facilitates the diffusion of the anesthetics through nerve 
cell membranes. Therefore, its efficiency is improved. However, the amine portion provides 
lipophobic and hydrophilic properties and can become soluble for injection. The intermediate 
connecting chain provides the main anesthetic properties and classifies the local anesthetics 
into two groups: the amino amides and the amino esters [5].
Amide anesthetics—these anesthetics all have an amide linkage (i.e., bupivacaine, ropiva-
caine, lidocaine, prilocaine, mepivacaine). They are metabolized by microsomal enzymes in 
the liver and excreted by the kidneys. Decreased liver function may lead to amide anesthetics 
toxic effects [2, 6].
Ester anesthetics—they have an ester linkage (i.e., procaine, chloroprocaine, tetracaine, 
benzocaine, cocaine). The ester anesthetics use to have a shorter duration. They are hydro-
lyzed by plasma pseudocholinesterases and excreted by the kidneys. Decreased levels of 
plasma pseudocholinesterases may lead to toxic effects. The metabolite para-aminobenzoic 
acid (PABA) is a major metabolic product and is associated with higher incidence of aller-
gies [2, 6].
The main properties of anesthetics are potency, toxicity, onset of action, and duration of action 
(Table 1). Lipid solubility use to be directly associated with potency as the compound pen-
etrates the nerve cells more easily. The protein type and its capacity of maintain the sodium 
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channels receptor binding is association with duration of action. The dissociation constant 
(pKa) determines the proportion of the anesthetics base and its cation at a given pH and 
is associated with shorter onset of action and less toxicity. However, if the pH is raised too 
much, the anesthetic may precipitate out of solution [7].
Lidocaine is labeled pregnancy category B. However, it is recommended that lidocaine and 
all other anesthetic agents be used warily during first trimester of pregnancy. The anesthetic 
agents commonly cross the placenta barrier and achieve the fetus. For use in children, the 
maximum recommended dosage should be adjusted to child’s weight. In infants, prilocaine is 
associated with major risk of methemoglobinemia [8] (Tables 2 and 3).
Anesthetic pKa Onset 
(min)
Duration 
(min) without 
epinephrine
Duration 
(min) with 
epinephrine
Max dose (mg/
kg) without 
epinephrine
Max dose (mg/kg) 
with epinephrine
Chloroprocaine 9 5–6 30–60 N/A 11 14
Procaine 8.9 5 30–90 30–180 10 14
Tetracaine 8.6 7 120–240 240–480 2 2
Bupivacaine 8.1 2–10 120–240 240–480 2.5 3
Etidocaine 7.7 3–5 200 240–360 4.5 6.5
Lidocaine 7.7 <1 30–120 60–400 5 7
Mepivacaine 7.6 3–20 30–120 60–400 6 7
Prilocaine 7.7 5–6 30–120 60–400 7 10
Ropivacaine 8.2 1–15 120–360 Not yet defined 3.5 Not yet defined
Kouba et al. [9].
Table 1. Properties of local anesthetics.
Table 2. Anesthetics used for local infiltration.
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3. Additions to local anesthetics
Many additives to local anesthetics have been studied. The aim of making complex anesthetic’s 
solutions is to achieve better efficacy and safety during dermatologic surgery.
3.1. Other anesthetics
We can mix different local anesthetics in an attempt to take advantage of useful properties of 
each drug. For example, short-duration anesthetics like lidocaine can be mixed with a long-
duration one like ropivacaine in an attempt to gain in durability. As well as, longer onset 
anesthetics can be mixed with shorter ones. However, this kind of association is not as logical 
as it seems, the nerve blockades obtained by mixing commercially available solutions of local 
anesthetics are unpredictable and may depend on a number of factors, which include not 
only the types of drugs but also the pH of the mixture. It is possible also to inject a rapid-onset 
anesthetic first to a longer-onset anesthetic, without mixing them [10].
3.2. Vasoconstrictors
Most local anesthetics promote vasodilatation by relaxation of vascular smooth muscle. 
Cocaine is the only example of local anesthetics that promotes vasoconstriction, and ropiva-
caine seems to be a local anesthetic that causes neither vasodilatation nor vasoconstriction. 
Cocaine is a norepinephrine reuptake inhibitor, thus potentiating sympathetic stimulation 
and causing hypertension and ventricular irritability.
Vasoconstriction at the operative site is commonly intended because it promotes less bleeding 
and facilitates the ease of surgery. Moreover, vasodilatation increases systemic absorption of 
anesthetics solution decreasing duration and efficacy of the anesthesia and increasing also 
systemic toxicity. Therefore, epinephrine can be useful decreasing bleeding and anesthetics 
systemic toxicity, and increasing their efficacy and duration [11].
Epinephrine is widely used in dermatologic surgery to promote vasoconstriction. It typically 
requires 5–15 min to reach full vasoconstriction effect. There are premixed solutions with 
epinephrine at a concentration of 1:100,000 and 1:200,000. However, effective vasoconstriction 
is achieved with a 1:100,000 concentration and risks of side effects are greater in 1:200,000 
Kouba et al. [9].
Table 3. Anesthetics for topical use.
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concentration. The maximum dose is 1 mg over approximately 8–10 h; however, this dosage 
should be much lower (or even absent) depending on patient age and concomitant health 
issues [12, 13]. Physicians using local anesthetic with epinephrine should be aware of this 
interaction. Epinephrine is a strong β- and α-agonist and can cause severe hypertension in 
patients using β-blocker medications [14]. Patients with severe cardiovascular disease may 
have their underlying diseases exacerbated with epinephrine use, as well as patients with nar-
row angle glaucoma. Patients taking monoamine oxidase inhibitors, tricyclic antidepressant, 
and phenothiazines are more sensitive to epinephrine. However, absolute contraindications 
to their use are hyperthyroidism and pheochromocytoma.
Systemic side effects of epinephrine can be self-limited or leaves to death. Therefore, it is 
important to avoid unintentional intravascular injection of epinephrine. Self-limited side 
effects include palpitations, anxiety, sweating, tremor, tachycardia, and elevated blood pres-
sure. These signs and symptoms usually resolve within a few minutes, but the patient must 
be under continuous monitorization to identify a serious side effect. Serious side effects of 
epinephrine include cardiovascular and cerebral suffering. Arrhythmias, tachycardias, and 
ventricular fibrillation are between the most common severe side effects.
Epinephrine is labeled pregnancy category C. The effect of pregnancy on arterial sensitivity to 
vasoconstrictors is controversial. Pregnancy was demonstrated to be associated with a signifi-
cant reduction in both uterine artery response and sensitivity to norepinephrine, epinephrine, 
and phenylephrine. However, there was no consistent pregnancy-associated effect on carotid 
artery response and sensitivity [15]. This reduction in artery response can be related to a 
fetal suffering, particularly in the first semester, and a premature labor in the third semester. 
Thereby, it is prudent to postpone nonurgent procedures requiring the use of epinephrine 
until after pregnancy.
Epinephrine found commercially available with lidocaine in premixed solutions contains 
acidic preservatives, such as sodium metabisulfite and citric acid [16]. As lower pH solutions 
use to cause more pain on injection, fresh lidocaine and epinephrine solutions are preferred 
than commercially lidocaine and epinephrine solutions [17].
The use of epinephrine on digits may prolong the duration of anesthesia and reduce the risk 
of bleeding during surgery, but it has been associated once with digital necrosis caused by 
vasoconstriction. Recent big studies recurrently demonstrate that evidence is insufficient to 
recommend use or avoidance of adrenaline in digital nerve blocks. However, there are case 
reports describing digital necrosis after injection of lidocaine with epinephrine. These digi-
tal necrosis cases can be as associated with vessel compression, constricting circumferential 
dressings, tourniquets, infection, hematoma, or patient’s vascular disease. In absence of these 
conditions, the use of epinephrine on digits seems to be safe. However, if a tourniquet is used 
during the surgery, there is no benefit of using also epinephrine to control bleeding [18–20].
3.3. Sodium bicarbonate
Lower pH solutions use to cause more pain on injection [17]. That is why the pain of infiltrat-
ing lidocaine with epinephrine into skin is reduced by the addition of sodium bicarbonate. 
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Adding sodium bicarbonate to anesthetic solution of lidocaine plus epinephrine in a pro-
portion of 1–10 can raise the solution’s pH from approximately 5.0 to approximately 7.5. As 
epinephrine concentration declined approximately 25% per week in anesthetic solution con-
taining sodium bicarbonate, it is recommended to use fresh solutions [21, 22].
In addition, alkalinization of local anesthetics solutions leads to a faster onset of action 
and a better anesthetic efficacy. However, it declines the duration of both anesthesia and 
vasoconstriction.
3.4. Hyaluronidase
Hyaluronidase is an enzyme that depolymerizes hyaluronic acid. Despite it is famous in cor-
recting acid hyaluronic fillers defect, it can be used in dermatologic surgery as an addition to 
local anesthetics by facilitating diffusion of solutions through tissue planes further away from 
the injection point. Although the duration of anesthesia is slightly decreased, the addition of 
hyaluronidase to local anesthesia offers the benefits of minimizing loss of surface contour and 
enhanced ease in undermining and dissection through subcutaneous tissue planes [23, 24].
The decrease of anesthesia’s duration and the major toxicity are explained due to increased 
absorption of the solution. That is why the tumescent technique must be avoided in hyaluron-
idase solution. The dosage usually recommended is one ampule to 30 ml anesthetic solution.
4. Side effects
Local anesthetics side injection frequently causes pain and local edema. Transient bruise and 
motor nerve paralysis can also occur. These are common local side effects. More rarely is 
nerve injuries. Intraneural injection can cause nerve damage and prolonged sensory nerve 
paresthesia may develop.
Despite local anesthetic systemic toxicity (LAST) is relatively rare, it must be considered 
whenever local anesthetic is administered. Difficulties in the clearance of these drugs can also 
be an important cause of LAST.
Central nervous system toxicity is due to intracellular voltage-gated fast sodium channels 
blockage in neuronal tissue. It all begins with blockade of cerebral cortical inhibitory path-
ways, leading to excitation, sensory and visual disturbance, muscle twitching, and convul-
sions. Perioral paresthesia is a classic early manifestation of LAST. CNS depression comes 
later with dizziness, confusion, unconsciousness, coma, and respiratory arrest [25].
Cardiovascular toxicity can be expressed by different kinds of arrhythmias. Local anesthetics 
block sodium channels in cardiovascular conducting cells and reduce the rate of depolariza-
tion and propagation of action potentials. Thereby, PR, QRS, and ST intervals become larger 
increasing the risk of bradyarrhythmia and re-entrant tachyarrhythmias. Myocardial depres-
sion and changes in systemic vascular resistance is also described. Among the commonly 
used local anesthetics, bupivacaine is the most cardiotoxic one [26].
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Usually, central nervous systemic toxicity signs precede cardiovascular toxicity signs whereas 
it is not a rule. The majority of LAST events occurs within several minutes of local anesthetics 
injection, but onset of symptoms can be delayed up to 60 min. Intra-arterial injection of anes-
thetics deflagrates almost immediately the LAST symptoms, as in intravenous injection or in 
systemic abortion, and there is a delay in the onset of signs [27].
Risk factors for LAST include drug pharmacological properties, administration dynamics, and 
patient factors. Local anesthetics should be reduced by 15% in babies less than 4 months old due 
to immaturity of hepatic enzymes [28]. Elderly people can have clearance of anesthetics reduced. 
Renal dysfunction is not related to more LAST and routine dose reduction is usually unnecessary. 
Hepatic dysfunction is offset by an increased volume of distribution of anesthetic agents and injec-
tions doses should be limited accordingly to the severity of hepatic dysfunction. Severe cardiac 
dysfunction can cause reduced hepatic and renal perfusion taking to clearance deficiency. Pregnant 
patients also can have increased cardiac output in second and third semester pregnancy [29].
There are maximum doses permissible for each anesthetic agent, and it is usually bigger when 
vasoconstrictors are associated. However, LAST may occur despite adherence to these limits. 
Therefore, practitioners should always use the lowest dose necessary to achieve the desired 
result due to the significant risk of systemic toxicity [30].
Besides respect the maximum anesthetics dosage, it is important to avoid intravascular injec-
tion. Ultrasound-guided peripheral nerve blockade reduces risk of LAST [31].
The management of LAST is mainly clinical support. Intravenous access, oxygen, and stan-
dard monitoring should be a routine for all patients with suspect of LAST. However, there are 
other clinical evidences that must be distinct of LAST, as vasovagal or allergic reactions [32].
Vasovagal reactions are by far the most common situation that must be distinct of LAST. Patient 
anxiety can result in an increase in parasympathetic tone. Dizziness, nausea, distal paresthe-
sia, and hypotension are the main symptoms [33].
Although allergic reactions to anesthetics are commonly reported, true allergic reactions are actu-
ally rare. Local anesthetics are too small to be antigenic by themselves but are sufficiently alien to 
bind as haptens to tissues with antigenic properties. Up to 14 days are required to develop sen-
sitization (antibody production). Once sensitization occurs, exposure to fractional quantities of 
the offending agent invokes an antigen-antibody reaction. Responses are classified into four cat-
egories depending upon the response. Type I reactions are IgE-mediated and are characterized 
by a massive release of histamine, serotonin, leukotrienes, and other humoral substances from 
mast cells resulting in a sudden onset of bronchospasm, cardiovascular depression and airway 
compromise, otherwise known as anaphylaxis. This is a true medical emergency and requires 
immediate and aggressive treatment. Type IV reactions represent the other end of the spectrum. 
Characteristically, they have a slower onset, associated with a non-IgE mediated release of bio-
amines, including histamine. The severity of the reaction depends on the quantity of the media-
tor released and can vary from mild contact dermatitis to anaphylactoid shock [34, 35].
Allergies have been reported for each class of local anesthetics, but cross-over sensitivity does 
not occur. Ester local anesthetics are metabolized to a PABA-like compound, and anaphylaxis 
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has been reported. Amide local anesthetics sometimes contain the preservative methylpara-
ben, which has also been reported to cause severe allergic reactions. It is important to know 
which class of local anesthetic caused the reaction and avoid that class in the future [2].
Taking a thorough history in these cases and reviewing all relevant medical and dental records 
are the best way of doing it. Allergists usually carry out skin testing whereas they are equivo-
cal in a large percentage of cases [34].
5. Topical anesthetics
Topical anesthetics act on the peripheral nerve endings in the dermis or mucosa, reduce the 
sensation of pain at the site of application, and avoid local pain caused by needling. They are 
useful aids during dermatologic treatment, especially in children, by mitigating discomfort 
and pain. Topical anesthetics also avoid tissue edema and surgical site distortions [36].
Their delivery and effectiveness can be enhanced by using free bases, by increasing the 
drug concentration, lowering the melting point, by using physical and chemical permeation 
enhancers and lipid delivery vesicles. Topical anesthetics are also able to penetrate mucosal 
surfaces, such as the mouth, genitals, and conjunctiva more easily than through a keratinized 
surface because of the absence of a stratum corneum [37].
Topical anesthetics seem to be safe, whereas systemic absorption occurs and systemic toxic 
events must be prevented. Extra caution is needed in damaged skin barrier, in infants, in 
mucosa, and in the extension of the applied corporal area [38].
The discovery of various amide and ester local anesthetics, their topical preparations and 
delivery systems in due course of time opened the gate of immense possible uses of topical 
anesthetics. The main topical anesthetics for mucous membrane and intact skin are benzo-
caine, dibucaine, lidocaine, prilocaine, proparacaine, and tetracaine. They exist in isolated 
form or in mixed different formulas.
Cryoanesthesia is the reduction of pain by applying cold agents to the skin. Various topical 
freezing agents are available: applying ice to the skin, the use of cooled gel or a cold glass, 
vapocoolant equipments, and cryogen sprays. The efficacy of cryoanesthesia is variable, and 
it has risk of causing scars and hyper or hypopigmentation [39].
6. Anesthetic injection techniques
Local anesthetic injection is often cited in literature as the most painful part of minor proce-
dures. It is also very possible for all doctors to get better at giving local anesthesia with less 
pain for patients [40].
The pain of needle insertion can be reduced by verbal distraction, massage at neighborhood 
of the local of injection, pinching, quick and right need injection, the use of previously topic 
Dermatologic Surgery and Procedures10
anesthetics, and accessory vibratory and cooler equipments. Small needles are related to less 
pain also. Additional sticks should be through an already numb area, and the injection should 
start on the side that the sensory innervations are coming from.
Sometimes, the injection of the anesthetic solution is more painful than the needle insertion 
itself due to tissue distension and solutions’ pH. To minimize tissue distension, the slowly injec-
tion of the anesthetic fluid is recommended. This is better obtained by the use of smaller needles 
and syringes. Subcutaneous injections promote less pain because of better tissue distension than 
intradermal injection. Acid solutions are usually associated with major pain. That is one reason 
why doctors associate sodium bicarbonate with anesthetic solutions. Intracutaneous instillation 
of lidocaine at body temperature is no less painful than injection at lower temperature [41].
Nerve block anesthesia also can minimize multiple anesthetics injection, besides decreasing 
the amount of solution need and its side effects. It is good to anesthetize large areas with little 
surface distortion. In general, nerve blocks cause less discomfort to the patient, especially 
during a mucosal approach. The correct technique involves injection of the anesthetic solution 
around the nerve, never into the nerve, to avoid nerve injuries. It is important to remember 
the presence of accompanying vein and artery to the nerve. Caution is needed to prevent 
intravascular injection. Intraforaminal injection is not recommended due to nerve compres-
sion. It is recommended to wait for about 5–10 min for full effectiveness of nerve blocks [4].
Field block anesthesia is a technique used mainly in cyst and skin cancer surgery. Field block 
anesthesia involves injecting anesthetic solution around the proposed surgical site, thereby 
blocking surrounding innervations. It is useful to avoid tumor transection. There are case reports 
of neoplasm surgical skin implantation. That is why field block anesthesia is recommended. 
Puncturing the cyst during surgery should also be avoided to decrease cyst recurrent [42].
Tumescent anesthesia is technique, which consists in infiltrating a large volume of dilute anes-
thetic and epinephrine solution to produce swelling and firmness of the target areas. It was first 
described by Kein and Lillis for liposuction surgery. The tumescent technique for local anesthe-
sia has made it possible to do liposuction, dermabrasion, facelifts, carbon dioxide laser full-face 
resurfacing, hair transplants, and large cutaneous excisions and repairs totally by local anesthe-
sia without intravenous sedation or narcotic analgesia. These benefits are optimizing biochemi-
cal compartments, maximizing drug concentration locally, delaying systemic drug absorption, 
decreasing systemic toxicity, prolonging local anesthetic effects, and benefiting from augmented 
local hydrostatic pressure to reduce bleeding and facilitate tissue dissection [43, 44]. Lidocaine is 
the most used anesthetic agent, whereas prilocaine also seems to be safe and effective [45]. There 
is no data examining other anesthetics for use in tumescent local anesthesia.
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